Miriam Enos is an experienced scientist with a robust background in translational biology, epigenetics, and therapeutic development. At Harvard Medical School, significant contributions included optimizing targeted therapies for Castration Resistant Prostate Cancer through comprehensive functional studies. At Moderna, roles evolved from Senior Scientist to Principal Scientist, focusing on developing high-throughput screening platforms and driving the development of mRNA tools for immune therapeutics. Noteworthy achievements at Moderna include a provisional patent filed for innovative epigenetic-based tools. Miriam Enos holds a PhD in Genetics from Tufts University School of Medicine and a combined MS/BS in Biochemistry and Molecular Biology from Brandeis University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices